Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Geriatr Psychiatry ; 20(5): 485-8, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15852461

RESUMO

BACKGROUND: Attentional function is impaired in Alzheimer's disease (AD). Moreover, attention is mediated by acetylcholine. But, despite the widespread use of acetylcholinesterase inhibitors (AChE-I) to augment available acetylcholine in AD, measures of attentional function have not been used to assess the drug response. OBJECTIVES: We hypothesized that as cholinergic augmentation impacts directly on the attentional system, higher-order measures of visual selective attention would be sensitive to effects of treatment using an AChE-I (donepezil hydrochloride). We also sought to determine whether these attentional measures were more sensitive to treatment than other measures of cognitive function. METHODS: Seventeen patients with AD (8 untreated, 9 treated with donepezil) were contrasted on performance of a selective cancellation task. Two signal detection parameters were used as outcome measures: decision strategy (beta, beta) and discriminability (d-prime, d'). Standard screening and cognitive domain measures of vigilance, language, memory, and executive function were also contrasted. RESULTS: Treated patients judged stimuli more conservatively (p = 0.29) by correctly endorsing targets and rejecting false alarms. They also discriminated targets from distractors more easily (p = 0.58). The screening and neuropsychological measures failed to differentiate the groups. CONCLUSIONS: Higher-order attentional measures captured the effects of donepezil treatment in small groups of patients with AD. The results suggest that cholinergic availability may directly affect the attentional system, and that these selective attention measures are sensitive markers to detect treatment response.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Atenção/efeitos dos fármacos , Inibidores da Colinesterase/farmacologia , Indanos/farmacologia , Piperidinas/farmacologia , Detecção de Sinal Psicológico/efeitos dos fármacos , Idoso , Doença de Alzheimer/psicologia , Cognição/efeitos dos fármacos , Tomada de Decisões/efeitos dos fármacos , Discriminação Psicológica/efeitos dos fármacos , Donepezila , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Reconhecimento Visual de Modelos/efeitos dos fármacos , Estimulação Luminosa/métodos
2.
Neuropsychology ; 19(1): 5-17, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15656758

RESUMO

A multitarget visual cancellation test was administered to patients with Alzheimer's disease (AD) and age-matched healthy controls (HC). Attentional loads--physical similarity (number of features shared by target and distractors; 3 levels) and density (number of items per page; 3 levels)--were varied systematically. As physical similarity increased, both groups slowed their search, but whereas the HC group maintained accuracy, the AD group increased commission errors and tended to miss more targets. Increased density yielded slower search and more target omissions in the AD group. Commission errors are additional indicators of higher order attentional deficits, especially in early disease. The findings suggest that patients with AD may rely increasingly on physical features of stimuli during a search, leading to inefficient bottom-up processing strategies.


Assuntos
Doença de Alzheimer/fisiopatologia , Atenção/fisiologia , Transtornos Cognitivos/fisiopatologia , Reconhecimento Visual de Modelos/fisiologia , Campos Visuais/fisiologia , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Estudos de Casos e Controles , Demografia , Feminino , Humanos , Masculino , Testes Neuropsicológicos/estatística & dados numéricos , Estimulação Luminosa/métodos , Tempo de Reação/fisiologia , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...